×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EW – edwards lifesciences corporation (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EW
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
09:34 am
ew
Relief Cardiovascular Appoints Harry Rowland as Chairman of the Board [Yahoo! Finance]
Low
Report
Relief Cardiovascular Appoints Harry Rowland as Chairman of the Board [Yahoo! Finance]
12/18
08:43 am
ew
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $100.00 price target on the stock, up previously from $90.00.
Low
Report
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $100.00 price target on the stock, up previously from $90.00.
12/18
07:10 am
ew
Edwards Lifesciences (NYSE:EW) was given a new $100.00 price target on by analysts at Wells Fargo & Company.
Low
Report
Edwards Lifesciences (NYSE:EW) was given a new $100.00 price target on by analysts at Wells Fargo & Company.
12/18
07:05 am
ew
Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/17
10:38 am
ew
Transcatheter Heart Valve Replacement Market Size to Reach USD 19.98 Billion by 2033, Growing at a CAGR of 15.32% – SNS Insider [Yahoo! Finance]
Low
Report
Transcatheter Heart Valve Replacement Market Size to Reach USD 19.98 Billion by 2033, Growing at a CAGR of 15.32% – SNS Insider [Yahoo! Finance]
12/17
10:05 am
ew
Edwards Lifesciences (NYSE:EW) was given a new $87.00 price target on by analysts at Canaccord Genuity Group Inc..
Low
Report
Edwards Lifesciences (NYSE:EW) was given a new $87.00 price target on by analysts at Canaccord Genuity Group Inc..
12/16
07:08 am
ew
Edwards Lifesciences (NYSE:EW) was given a new $87.00 price target on by analysts at Robert W. Baird.
Low
Report
Edwards Lifesciences (NYSE:EW) was given a new $87.00 price target on by analysts at Robert W. Baird.
12/15
01:09 pm
ew
Global Interventional Cardiology Devices Market is Predicted to Cross ~USD 30 Billion by 2034, Due to the Rising Cardiovascular Disease Burden | DelveInsight [Yahoo! Finance]
Low
Report
Global Interventional Cardiology Devices Market is Predicted to Cross ~USD 30 Billion by 2034, Due to the Rising Cardiovascular Disease Burden | DelveInsight [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
10/30/2025
04:13 pm
ew
edwards lifesciences corporation
BEAT
Report
-1.2%
edwards lifesciences corporation
7/24/2025
04:15 pm
ew
edwards lifesciences corporation
BEAT
Report
5.5%
edwards lifesciences corporation
4/23/2025
04:15 pm
ew
edwards lifesciences corporation
BEAT
Report
6.6%
edwards lifesciences corporation
2/11/2025
04:15 pm
ew
edwards lifesciences corporation
BEAT
Report
6.6%
edwards lifesciences corporation
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/12
05:58 pm
ew
Form 4 Edwards Lifesciences For: Dec 12 Filed by: Lippis Daniel J.
Low
Report
Form 4 Edwards Lifesciences For: Dec 12 Filed by: Lippis Daniel J.
12/12
05:58 pm
ew
Form 4 Edwards Lifesciences For: Dec 12 Filed by: STONE HEISZ LESLIE
Low
Report
Form 4 Edwards Lifesciences For: Dec 12 Filed by: STONE HEISZ LESLIE
12/12
05:58 pm
ew
Form 4 Edwards Lifesciences For: Dec 12 Filed by: BOBO DONALD E JR
Low
Report
Form 4 Edwards Lifesciences For: Dec 12 Filed by: BOBO DONALD E JR
12/12
04:22 pm
ew
Form 144 Edwards Lifesciences Filed by: BOBO DONALD E JR
Low
Report
Form 144 Edwards Lifesciences Filed by: BOBO DONALD E JR
12/12
04:05 pm
ew
Form 144 Edwards Lifesciences Filed by: STONE HEISZ LESLIE
Low
Report
Form 144 Edwards Lifesciences Filed by: STONE HEISZ LESLIE
12/12
04:04 pm
ew
Form 144 Edwards Lifesciences Filed by: BOBO DONALD E JR
Low
Report
Form 144 Edwards Lifesciences Filed by: BOBO DONALD E JR
12/11
05:59 pm
ew
Form 4 Edwards Lifesciences For: Dec 11 Filed by: Chopra Daveen
Low
Report
Form 4 Edwards Lifesciences For: Dec 11 Filed by: Chopra Daveen
12/11
04:01 pm
ew
Form 144 Edwards Lifesciences Filed by: Chopra Daveen
Low
Report
Form 144 Edwards Lifesciences Filed by: Chopra Daveen
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/23
Form 4 Edwards Lifesciences For: Mar 23 Filed by: Szyman Catherine M.
17.6%
7/23 Q2/2019 6/30/2019 EPS 1.380 ZacksConsensus 1.320 ActVsEst 0.060 - Beat 9.8%
4/1 Form 4 Edwards Lifesciences For: Apr 01 Filed by: Lemercier Jean-Luc M 6.9%
3/9 Form 4 Edwards Lifesciences For: Mar 06 Filed by: BOBO DONALD E JR 6.2%
4/16 Form 4 Edwards Lifesciences For: Apr 16 Filed by: Szyman Catherine M. 5.0%
4/13 Form DEFA14A Edwards Lifesciences 4.9%
3/25 Form DEFA14A Edwards Lifesciences 4.5%
4/9 Edwards Lifesciences Corp (NYSE: EW) had its price target lowered by analysts at Raymond James from $263.00 to $230.00. They now have an "outperform" rating on the stock. 4.1%
10/25 Form 10-Q Edwards Lifesciences For: Sep 30 4.0%
2/3 Form 4 Edwards Lifesciences For: Feb 03 Filed by: Lemercier Jean-Luc M 3.7%
7/23 Q2/2019 6/30/2019 EPS 1.380 ZacksConsensus 1.320 ActVsEst 0.060 - Beat 9.8%
4/1 Form 4 Edwards Lifesciences For: Apr 01 Filed by: Lemercier Jean-Luc M 6.9%
3/9 Form 4 Edwards Lifesciences For: Mar 06 Filed by: BOBO DONALD E JR 6.2%
4/16 Form 4 Edwards Lifesciences For: Apr 16 Filed by: Szyman Catherine M. 5.0%
4/13 Form DEFA14A Edwards Lifesciences 4.9%
3/25 Form DEFA14A Edwards Lifesciences 4.5%
4/9 Edwards Lifesciences Corp (NYSE: EW) had its price target lowered by analysts at Raymond James from $263.00 to $230.00. They now have an "outperform" rating on the stock. 4.1%
10/25 Form 10-Q Edwards Lifesciences For: Sep 30 4.0%
2/3 Form 4 Edwards Lifesciences For: Feb 03 Filed by: Lemercier Jean-Luc M 3.7%
TOP News Decliners
1/30
Form 8-K Edwards Lifesciences For: Jan 30
-10.6%
4/24 Edwards Lifesciences Corp (NYSE: EW) had its "buy" rating re-affirmed by analysts at Citigroup Inc. They now have a $255.00 price target on the stock, up previously from $240.00. -5.7%
3/20 Form 4 Edwards Lifesciences For: Mar 19 Filed by: MUSSALLEM MICHAEL A -5.1%
4/27 Edwards Lifesciences Corp (NYSE: EW) had its "underweight" rating re-affirmed by analysts at Barclays PLC. They now have a $155.00 price target on the stock, down previously from $165.00. -5.0%
10/24 Edwards Lifesciences Corp (NYSE: EW) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $255.00 price target on the stock, up previously from $240.00. -4.0%
4/28 Edwards Lifesciences Corp (NYSE: EW) was downgraded by analysts at Wells Fargo & Co from an "overweight" rating to an "equal weight" rating. -3.5%
4/30 Form 4 Edwards Lifesciences For: Apr 30 Filed by: Szyman Catherine M. -3.1%
3/30 Form 4 Edwards Lifesciences For: Mar 30 Filed by: WANG HUIMIN -3.0%
9/6 Form 4 Edwards Lifesciences For: Sep 06 Filed by: BOBO DONALD E JR -2.7%
3/2 Form 4 Edwards Lifesciences For: Mar 02 Filed by: Wood Larry L -2.5%
4/24 Edwards Lifesciences Corp (NYSE: EW) had its "buy" rating re-affirmed by analysts at Citigroup Inc. They now have a $255.00 price target on the stock, up previously from $240.00. -5.7%
3/20 Form 4 Edwards Lifesciences For: Mar 19 Filed by: MUSSALLEM MICHAEL A -5.1%
4/27 Edwards Lifesciences Corp (NYSE: EW) had its "underweight" rating re-affirmed by analysts at Barclays PLC. They now have a $155.00 price target on the stock, down previously from $165.00. -5.0%
10/24 Edwards Lifesciences Corp (NYSE: EW) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $255.00 price target on the stock, up previously from $240.00. -4.0%
4/28 Edwards Lifesciences Corp (NYSE: EW) was downgraded by analysts at Wells Fargo & Co from an "overweight" rating to an "equal weight" rating. -3.5%
4/30 Form 4 Edwards Lifesciences For: Apr 30 Filed by: Szyman Catherine M. -3.1%
3/30 Form 4 Edwards Lifesciences For: Mar 30 Filed by: WANG HUIMIN -3.0%
9/6 Form 4 Edwards Lifesciences For: Sep 06 Filed by: BOBO DONALD E JR -2.7%
3/2 Form 4 Edwards Lifesciences For: Mar 02 Filed by: Wood Larry L -2.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: